Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Accepts healthy volunteers Results available

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

ClinicalTrials.gov ID: NCT03982199

Public ClinicalTrials.gov record NCT03982199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 5:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Phase 2b Study to Assess the Efficacy, Immunogenicity and Safety of an Ad26.RSV.preF-based Regimen in the Prevention of RT PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

Study identification

NCT ID
NCT03982199
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Vaccines & Prevention B.V.
Industry
Enrollment
5,815 participants

Conditions and interventions

Interventions

  • Placebo Biological
  • RSV Vaccine Biological

Biological

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2019
Primary completion
Jun 5, 2022
Completion
May 25, 2023
Last update posted
May 24, 2025

2019 – 2023

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Optimal Research Huntsville Alabama 35802
Synexus Clinical Research US Inc Chandler Arizona 85224
Synexus Clinical Research US Inc Phoenix Arizona 85018
Central Phoenix Medical Clinic Phoenix Arizona 85020
Anaheim Clinical Trials, LLC Anaheim California 92801
Paradigm Clinical Research Centers, Inc. Redding California 96001
Benchmark Research Sacramento California 95684
Optimal Research San Diego California 92108
Synexus Clinical Research US Inc Aurora Colorado 80014
Lynn Institute Colorado Springs Colorado 80920
Optimal Research Melbourne Florida 32934
Advanced Clinical Research Boise Idaho 83642
Optimal Research Peoria Illinois 61614
Synexus Clinical Research US Inc Evansville Indiana 47714
The Iowa Clinic West Des Moines Iowa 50266
Hutchinson Clinic Hutchinson Kansas 67502
Johnson County Clin-Trials Lenexa Kansas 66219
Heartland Research Associates, LLC Newton Kansas 67114
Heartland Research Associates, LLC Wichita Kansas 67205
Optimal Research Rockville Maryland 20850
Synexus Clinical Research US Inc Richfield Minnesota 55432
The Center For Pharmaceutical Research Kansas City Missouri 64114
Sundance Clinical Research St Louis Missouri 63141
Synexus Clinical Research US Inc St Louis Missouri 63141
Synexus Clinical Research US Inc Elkhorn Nebraska 68022
Synexus Clinical Research US Inc Omaha Nebraska 68144
United Medical Associates Binghamton New York 13901
Regional Clinical Research, Inc. Endwell New York 13760
University of Rochester / Rochester General Hospital Rochester New York 14621
Synexus Clinical Research US Inc Akron Ohio 44311
Synexus Clinical Research US Inc Cincinnati Ohio 45236
Rapid Medical Research Cleveland Ohio 44122
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Omega Medical Research Warwick Rhode Island 02886
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Optimal Research Austin Texas 78705
Ventavia Research Group, LLC Fort Worth Texas 76104
Synexus Clinical Research US Inc Murray Utah 84123
Advanced Clinical Research Salt Lake City Utah 84123
Advanced Clinical Research West Jordan Utah 84088

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03982199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03982199 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →